"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 3 | 5 |
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 1 | 2 |
| 1998 | 2 | 5 | 7 |
| 1999 | 1 | 3 | 4 |
| 2000 | 1 | 1 | 2 |
| 2001 | 3 | 3 | 6 |
| 2002 | 5 | 3 | 8 |
| 2003 | 9 | 9 | 18 |
| 2004 | 39 | 34 | 73 |
| 2005 | 28 | 22 | 50 |
| 2006 | 19 | 19 | 38 |
| 2007 | 14 | 17 | 31 |
| 2008 | 12 | 13 | 25 |
| 2009 | 8 | 10 | 18 |
| 2010 | 4 | 12 | 16 |
| 2011 | 12 | 8 | 20 |
| 2012 | 6 | 14 | 20 |
| 2013 | 21 | 16 | 37 |
| 2014 | 23 | 23 | 46 |
| 2015 | 15 | 21 | 36 |
| 2016 | 19 | 36 | 55 |
| 2017 | 204 | 223 | 427 |
| 2018 | 205 | 213 | 418 |
| 2019 | 69 | 117 | 186 |
| 2020 | 501 | 359 | 860 |
| 2021 | 608 | 613 | 1221 |
| 2022 | 2 | 9 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma. Eur Respir J. 2022 02; 59(2).
-
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients. J Natl Cancer Inst. 2022 Feb 07; 114(2):203-209.
-
False-Positive Rates in Pediatric SARS-CoV-2 Serology Testing. Am J Clin Pathol. 2022 02 03; 157(2):314-316.
-
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera. J Mol Cell Biol. 2022 01 29; 13(12):918-920.
-
Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer. Am J Clin Pathol. 2022 01 06; 157(1):109-118.
-
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273. JAMA. 2021 Oct 19; 326(15):1533-1535.
-
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19. J Clin Invest. 2021 10 15; 131(20).
-
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection. J Clin Invest. 2021 10 15; 131(20).
-
Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021. JAMA. 2021 10 12; 326(14):1436-1438.
-
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. J Intern Med. 2022 01; 291(1):72-80.